Sharon Shacham

2016

In 2016, Sharon Shacham earned a total compensation of $1.4M as President and Chief Scientific Officer at Karyopharm Therapeutics, a 69% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$166,000
Option Awards$758,523
Salary$415,000
Other$11,260
Total$1,350,783

Shacham received $758.5K in option awards, accounting for 56% of the total pay in 2016.

Shacham also received $166K in non-equity incentive plan, $415K in salary and $11.3K in other compensation.

Rankings

In 2016, Sharon Shacham's compensation ranked 6,771st out of 14,075 executives tracked by ExecPay. In other words, Shacham earned more than 51.9% of executives.

ClassificationRankingPercentile
All
6,771
out of 14,075
52nd
Division
Manufacturing
2,528
out of 5,489
54th
Major group
Chemicals And Allied Products
822
out of 1,895
57th
Industry group
Drugs
631
out of 1,538
59th
Industry
Pharmaceutical Preparations
498
out of 1,176
58th
Source: SEC filing on April 28, 2017.

Shacham's colleagues

We found three more compensation records of executives who worked with Sharon Shacham at Karyopharm Therapeutics in 2016.

2016

Michael Kauffman

Karyopharm Therapeutics

Chief Executive Officer

2016

Justin Renz

Karyopharm Therapeutics

Chief Financial Officer

2016

Christopher Primiano

Karyopharm Therapeutics

General Counsel

News

In-depth

You may also like